REVVITY, INC Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- REVVITY, INC payments for repurchase of common stock for the quarter ending 2026-07-05 was $15.99M, a 94.56% decline year-over-year.
- REVVITY, INC payments for repurchase of common stock for the quarter ending 2026-04-05 was $86.50M, a 43.69% decline year-over-year.
- REVVITY, INC payments for repurchase of common stock for the quarter ending 2025-12-28 was $168.28M, a 9.11% decline year-over-year.
- REVVITY, INC payments for repurchase of common stock for the quarter ending 2025-09-28 was $205.03M, a 33.04% increase year-over-year.
- REVVITY, INC payments for repurchase of common stock for fiscal 2025 was $820.82M, a 122.10% increase from fiscal 2024.
- REVVITY, INC payments for repurchase of common stock for fiscal 2024 was $369.58M, a 4.96% decline from fiscal 2023.
- REVVITY, INC payments for repurchase of common stock for fiscal 2023 was $388.88M, a 382.26% increase from fiscal 2023.
- REVVITY, INC payments for repurchase of common stock for fiscal 2023 was $80.64M, a 10.35% increase from fiscal 2022.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-07-05 | $15.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $475.80M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-04-05 | $86.50M 10-Q · filed 2026-05-12 | $753.72M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-28 | $168.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $820.82M 10-K · filed 2026-02-24 |
| 2025-09-28 | $205.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $837.69M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-29 | $293.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $786.77M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-30 | $153.59M 10-Q · filed 2026-05-12 | $512.42M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-29 | $185.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $369.58M 10-K · filed 2026-02-24 |
| 2024-09-29 | $154.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $189.29M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $19.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $145.89M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $10.76M 10-Q · filed 2025-05-06 | $337.98M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $388.88M 10-K · filed 2026-02-24 |
| 2023-10-01 | $110.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $408.51M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-07-02 | $211.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $297.89M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-04-02 | $61.66M 10-Q · filed 2024-05-07 | $86.70M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-01-01 | $24.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $80.64M 10-K · filed 2025-02-25 |
| 2022-10-02 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $56.20M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-03 | $456.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $56.20M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-03 | $55.59M 10-Q · filed 2023-05-12 | $85.89M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-02 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $73.07M 10-K · filed 2024-02-27 |
| 2021-10-03 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $73.13M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-07-04 | $30.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $73.20M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-04-04 | $42.78M 10-Q · filed 2022-05-10 | $43.38M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-01-03 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.94M 10-K · filed 2023-03-01 |
| 2020-10-04 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $6.94M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-07-05 | $327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $6.92M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-04-05 | $6.34M 10-Q · filed 2021-05-11 | $7.36M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-29 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $6.31M 10-K · filed 2022-03-03 |
| 2019-09-29 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $58.67M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | $764.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $58.85M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | $5.29M 10-Q · filed 2020-05-12 | $58.18M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-30 | $52.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $57.45M 10-K · filed 2021-03-02 |
| 2018-09-30 | $325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.33M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-07-01 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.22M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-04-01 | $4.55M 10-Q · filed 2019-05-07 | $5.26M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.83M 10-K · filed 2020-02-25 |
| 2017-10-01 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $3.83M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-02 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.71M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-02 | $3.13M 10-Q · filed 2018-05-08 | $3.77M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-01-01 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $151.80M 10-K · filed 2019-02-26 |
| 2016-10-02 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $151.73M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-07-03 | $192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $223.69M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-04-03 | $151.16M 10-Q · filed 2017-05-09 | $223.64M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-01-03 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $76.44M 10-K · filed 2018-02-27 |
| 2015-10-04 | $72.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $102.68M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-28 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $30.65M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-29 | $3.95M 10-Q · filed 2016-05-10 | $65.57M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-28 | $26.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $65.53M 10-K · filed 2017-02-28 |
| 2014-09-28 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $39.22M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-29 | $35.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $39.38M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-30 | $3.92M 10-Q · filed 2015-05-05 | $4.46M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-29 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $127.40M 10-K · filed 2016-03-01 |
| 2013-09-29 | $193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $127.20M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $127.03M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $126.86M 10-Q · filed 2014-05-06 | $127.33M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $2.10M 10-K · filed 2015-02-24 |
| 2012-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $2.09M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-07-01 | $431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $2.07M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-04-01 | $1.63M 10-Q · filed 2013-05-06 | $2.41M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-01-01 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $110.00M 10-K · filed 2014-02-25 |
| 2011-10-02 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $181.78M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-07-03 | $773.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $181.77M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-04-03 | $109.22M 10-Q · filed 2012-05-08 | $181.05M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-01-02 | $71.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $72.77M 10-K · filed 2013-02-26 |
| 2010-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $995.00K derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-07-04 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-10 | $1.03M derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-04-04 | $938.00K 10-Q · filed 2011-05-10 | |
| 2010-01-03 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $14.62M 10-K · filed 2012-02-28 |
| 2009-10-04 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | |
| 2008-12-28 | $75.51M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |